In summary, our findings identified a novel upregulated lncRNA LIPH-4, which functions as an oncogenic lncRNA during ESCC progression and reveals a ceRNA regulatory pathway in which LIPH-4 upregulates IGF2BP2 expression by sponging miR-216b. The gene discussed is IGF2BP2; the disease is esophageal squamous cell carcinoma.